Back to Trades
Other4
Maze Therapeutics, Inc.
MAZE
Total Value
$298.1K
Company Information
- Company Name
- Maze Therapeutics, Inc.
- Ticker Symbol
- MAZE
- CIK
- 0001842295
Insider Information
- Name
- Dandekar Atul
- Role
- Insider
- Location
- SOUTH SAN FRANCISCO, CA
Filing Details
- Filing Date
- May 6, 2026
- Transaction Date
- May 4, 2026
- Accession Number
- 0002050167-26-000010
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | 8,320 | $10.42 | Exercise | $86.7K |
| May 4, 2026 | Common Stock | 5,985 | $10.42 | Exercise | $62.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Derivative | 8,320 | $10.42 | Exercise | $86.7K |
| May 4, 2026 | Derivative | 5,985 | $10.42 | Exercise | $62.4K |
Footnotes
- (F1)The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 1, 2026.
- (F2)The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.